RecruitingNot ApplicableNCT07090733

Ultrasound Guided Interscalene, Suprascapular and Anterior Glenoid Nerve Blocks on Diaphragmatic Excursion and Analgesia Following Arthroscopic Shoulder Surgery

The Effect of Ultrasound Guided Interscalene, Suprascapular and Anterior Glenoid Nerve Blocks on Diaphragmatic Excursion and Analgesia Following Arthroscopic Shoulder Surgery: A Prospective Randomized Controlled Study


Sponsor

Tanta University

Enrollment

80 participants

Start Date

Jan 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the diaphragmatic movement and postoperative analgesia following anterior glenoid, suprascapular, and interscalene nerve blocks in patients undergoing elective arthroscopic shoulder surgery.


Eligibility

Min Age: 21 YearsMax Age: 65 Years

Inclusion Criteria4

  • Age from 21 to 65 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I or II.
  • Scheduled for arthroscopic shoulder surgery.

Exclusion Criteria8

  • Patient's refusal to participate.
  • Patients with a history of allergy to local anesthetics.
  • Patients with a history of chronic use of painkillers.
  • Patients presented with mental dysfunction.
  • Patients with coagulation disorders.
  • Patients presented with skin or soft tissue infection at the proposed site of needle Insertion.
  • Pregnant Patients.
  • Patients with Chronic Obstructive Pulmonary Disease (COPD) or a Body Mass Index (BMI) of more than 40.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERInterscalene brachial plexus block

Patients will receive general anesthesia, plus an ultrasound-guided interscalene brachial plexus block (ISB) with the injection of 15 mL of 0.25% bupivacaine.

OTHERSuprascapular nerve block

Patients will receive general anesthesia plus an ultrasound-guided suprascapular nerve block (SSNB) with injection of 15 ml of 0.25% bupivacaine.

OTHERAnterior glenoid block

Patients will receive general anesthesia plus an ultrasound-guided anterior glenoid block with injection of 15 ml of 0.25% bupivacaine.

OTHERSuprascapular nerve block + Anterior glenoid block

Patients will receive general anesthesia, along with a total volume of 30 mL of 0.25% bupivacaine, divided into 15 mL for ultrasound-guided SSNB and 15 mL for ultrasound-guided anterior glenoid block.


Locations(1)

Tanta University

Tanta, El-Gharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07090733


Related Trials